Literature DB >> 26444696

Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study.

Yukiko Fukuda1, Yoshitaka Hashimoto1, Masahide Hamaguchi1, Takuya Fukuda1, Naoto Nakamura1, Akihiro Ohbora2, Takahiro Kato2, Takao Kojima2, Michiaki Fukui1.   

Abstract

BACKGROUND: Triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) has been recommended for surrogates of insulin resistance. However, it remains to be elucidated the association between TG/HDL-C and incident fatty liver. AIMS: To investigate the association between TG/HDL-C and incident fatty liver.
METHODS: We performed population-based historical cohort study consisted with 4518 healthy Japanese who received yearly health-checkup programmes over decade. Fatty liver was diagnosed using ultrasonography.
RESULTS: During the observation periods, 38.8% (case/N = 1023/2637) of men and 17.2% (case/N = 324/1881) of women developed fatty liver. Adjusting odds ratio of TG/HDL-C for incident fatty liver were 1.59 (95% confidence interval (CI) 1.42-1.79, P < 0.0001) in men and 2.50 (95% CI 1.80-3.51, P < 0.0001) in women. In addition, adjusting odds ratio of TG/HDL-C for incident non-alcoholic fatty liver disease were 1.55 (95% CI 1.35-1.77, P < 0.0001) in men and 2.72 (95% CI 1.88-3.95, P < 0.0001) in women. According to the receiver operator characteristic (ROC) analysis, the optimal cut-off point of TG/HDL-C for incident fatty liver was 0.88 (area under the ROC curve (AUC) 0.67 [95% CI 0.65-0.69], sensitivity = 0.64, specificity = 0.60, P < 0.0001) in men and 0.64 (AUC 0.69 [95% CI 0.66-0.72], sensitivity = 0.50, specificity = 0.78, P < 0.0001) in women.
CONCLUSIONS: The TG/HDL-C could predict the incident fatty liver. Thus, it is important to check TG/HDL-C and lifestyles modification is needed for preventing future fatty liver disease in patients with high TG/HDL-C.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TG/HDL ratio; epidemiology; insulin resistance; metabolic syndrome; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2015        PMID: 26444696     DOI: 10.1111/liv.12977

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  32 in total

1.  Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients.

Authors:  S Ida; R Kaneko; H Nagata; Y Noguchi; Y Araki; M Nakai; S Ito; K Imataka; K Murata
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

3.  Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; Martinho Antonio Gestic; Murillo Pimentel Utrini; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

4.  Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.

Authors:  Zhi Liu; He He; Yuzhao Dai; Lidan Yang; Shenling Liao; Zhenmei An; Shuangqing Li
Journal:  Lipids Health Dis       Date:  2022-06-25       Impact factor: 4.315

5.  Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Authors:  Xin-Yao Liu; Qiao-Yu Wu; Zhi-Heng Chen; Guang-Yu Yan; Yao Lu; Hai-Jiang Dai; Ying Li; Ping-Ting Yang; Hong Yuan
Journal:  Endocrine       Date:  2020-01-15       Impact factor: 3.633

6.  Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-09-30       Impact factor: 3.633

7.  Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study.

Authors:  Hewei Peng; Xiaoxu Xie; Xinting Pan; Jing Zheng; Yidan Zeng; Xiaoling Cai; Zhijian Hu; Xian-E Peng
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

8.  Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

9.  Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals.

Authors:  Cristina López-Vicario; Bibiana Rius; José Alcaraz-Quiles; Ana González-Périz; Ana Isabel Martínez-Puchol; Mireia Casulleras; Marta Duran-Güell; Ainitze Ibarzabal; Ricard Corcelles; Andrés Laguna-Fernández; Magnus Back; Esther Titos; Joan Clària
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

10.  Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China.

Authors:  Liwei Ji; Xintian Cai; Yang Bai; Tao Li
Journal:  Int J Gen Med       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.